SEC 13F Intelligence

Trv GP IV, LLC / FULC

Trv GP IV, LLC’s Fulcrum Therapeutics Inc Position

Does Trv GP IV, LLC own Fulcrum Therapeutics Inc (FULC)? Not currently — the last reported position was 2.34M shares worth $8M in Q3 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$8M
Q3 2024
Shares
2.34M
% of Portfolio
+5.16%
Quarters Held
21
position exited

Position History FULC

Reported value by quarter
Q3 ’19: $16MQ3 ’19Q4 ’19: $39MQ1 ’20: $28MQ2 ’20: $43MQ2 ’20Q3 ’20: $19MQ4 ’20: $27MQ1 ’21: $28MQ1 ’21Q2 ’21: $25MQ3 ’21: $66MQ4 ’21: $41MQ4 ’21Q1 ’22: $55MQ2 ’22: $11MQ3 ’22: $19MQ3 ’22Q4 ’22: $17MQ1 ’23: $7MQ2 ’23: $8MQ2 ’23Q3 ’23: $10MQ4 ’23: $16MQ1 ’24: $22MQ1 ’24Q2 ’24: $15MQ3 ’24: $8Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 20242.34M$8M+5.16%
Q2 20242.34M$15M+7.18%
Q1 20242.34M$22M+10.72%
Q4 20232.34M$16M+6.43%
Q3 20232.34M$10M+3.92%
Q2 20232.34M$8M+6.99%
Q1 20232.34M$7M+4.77%
Q4 20222.34M$17M+7.25%
Q3 20222.34M$19M+11.08%
Q2 20222.34M$11M+7.55%
Q1 20222.34M$55M+20.30%
Q4 20212.34M$41M+11.92%
Q3 20212.34M$66M+15.00%
Q2 20212.34M$25M+11.69%
Q1 20212.34M$28M+10.17%
Q4 20202.34M$27M+8.80%
Q3 20202.34M$19M+6.40%
Q2 20202.34M$43M+19.74%
Q1 20202.34M$28M+25.58%
Q4 20192.34M$39M+24.31%
Q3 20192.34M$16M+15.92%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trv GP IV, LLC’s full portfolio or all institutional holders of FULC.